Organon & Co. surged 25% to an opening price of $10.75 on Monday after Sun Pharmaceutical Industries agreed to acquire the women’s health specialist in an all-cash deal valuing Organon at $11.75 billion, or $14.00 per share — a 103% premium to its April 9 unaffected close. Qualco